LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...

AngioDynamics (NASDAQ:ANGO) said that it has received breakthrough device designation from the FDA for its AngioVac System for the non-surgical removal of vegetation from the right heart. The ...

AngioDynamics, Inc. ANGO recently announced the receipt of the FDA’s Breakthrough Device designation for its AngioVac System for the proposed indications for use to include the non-surgical removal of ...

(RTTNews) - Shares of medical technology firm AngioDynamics, Inc. (ANGO) are rising more than 8% in pre-market on Wednesday after the company said on Tuesday that the FDA granted Breakthrough Device ...

Another mixed quarter in Q3 FY'22 for AngioDynamics, despite strengths in its international markets. Management revised guidance higher, but this may widen the operating loss as well, in my view.